参考文献/References:
[1]SHIRODE P,SETHI S K,NASCIMENTO D,et al.Tandem extracorporeal blood purification therapies for sepsis and acute kidney injury in critically ill children:A state-of-the-art review[J].Ren Fail,2026,48(1):2653939.
[2]黄盼盼,顾乔,曾小康.尿液肌动蛋白作为脓毒症相关急性肾损伤的生物标志物研究[J].空军军医大学学报,2022,43(8):984-989.
[3]韩文君,李晓凡,李欣,等.血必净联合乌司他丁对老年脓毒症患者多器官保护作用[J].临床误诊误治,2025,38(22):83-89.
[4]许青青,林瑶瑶,刘海林,等.血清人附睾分泌蛋白4、应激诱导蛋白2水平与脓毒症相关ARDS患者病情严重程度、预后的关系研究[J].实用心脑肺血管病杂志,2024,32(8):53-57.
[5]龙香宇,宋振举,邵勉.脓毒症患者肠道菌群及其代谢组学特征[J].中国临床医学,2026,33(1):65-73.
[6]罗智浩,陈凯立,陈磊,等.基于肠道菌群-免疫调节探讨增液承气汤调控TLR4/NF-κB通路对脓毒症肠功能障碍的影响[J].现代中西医结合杂志,2025,34(24):3389-3396.
[7]SINGER M,DEUTSCHMAN C S,SEYMOUR C W,et al.The thirdinternational consensus definitions for sepsis and septic shock (sepsis-3)[J].JAMA,2016,315(8):801-810.
[8]MICOLI F,RONDINI S,BERLANDA SCORZA F,et al.Vaccines preventing neonatal sepsis:Focus on Group B Streptococcus,Klebsiella pneumonia and Escherichia coli to combat rising antimicrobial resistance[J].Expert Rev Vaccines,2026,25(1):2622690.
[9]ADAME M D,STRINGER K A,DICKSON R P.The gut microbiome and short-chain fatty acid metabolites in sepsis[J].Clin Chest Med,2026,47(1):119-128.
[10]PHILIPS C A,OOMMEN T T,THERUVATH A H,et al.Novel insights on clinical outcomes using integrated shotgun metagenomic profiling of the gut microbiome,resistome,and host immune-inflammatory response in hospitalized patients with decompensated cirrhosis[J].Pathogens,2026,15(3):241.
[11]杨火保,刘进生,郑彩罚.脓毒症患者血清I-FABP、D-Lac、hs-CRP水平的变化及其临床意义[J].海南医学,2021,32(18):2331-2333.
[12]李志华,于湘友,王毅,等.血清iFABP和DAO对脓毒症及脓毒症肠道损伤的诊断及预后评判价值[J].海南医科大学学报,2025,31(4):270-276.
[13]李玉祥,石承先,张莹.急性胰腺炎胰腺一氧化氮合成酶和内皮素mRNA表达与肠道损伤的关系及丹参的影响[J].华西医学,2010,25(2):314-316.
[14]陈婕,张红梅,谭春艳.脓毒症患者肠道菌群生态特征与血清D-乳酸、sTREM1和MCP-1表达水平的相关性研究[J].现代检验医学杂志,2023,38(4):139-142,179.
[15]马梦瑾,李志洁.超标/肥胖儿童SCFAs含量与血脂及肠道菌群关系[J].青岛大学学报（医学版）,2025,61(6):921-925.
[16]郝秋红,杨晞,杨艳萍,等.解毒降浊颗粒对代谢综合征SD大鼠肠道菌群结构及TLR-4/NF-κB信号通路的影响[J].中国药学杂志,2020,55(8):595-603.
[17]DRESCHERS S,HEILER E,OPPERMANN L,et al.TLR7/8 signaling balances cytokine responses in neonatal monocytes[J].Sci Rep,2026,16(1):12202.
[18]BEIT YAAKOV S,ARGOV O,ROGOWSKI O,et al.Normoferritinemic versus hyperferritinemic inflammation in patients admitted to the department of internal medicine[J].J Clin Med,2026,15(7):2646.
[19]KIM Y,KIM Y K,LEE S,et al.Panax ginseng-derived exosome-like nanoparticles prevent LPS-induced septic shock by modulating TLR4 glycosylation in macrophages[J].Mol Pharm,2026,23(4):2274-2285.
[20]刘莉,吴晓颖,李兴泉.脓毒症患者中可溶性髓样细胞触发受体1、降钙素原、核因子κB水平与肠道菌群失调的相关性[J].微生物与感染,2021,16(4):256-260.
[21]詹雪,王郝.血清巨噬细胞移动抑制因子、单核细胞趋化因子-1水平联合毛细血管渗漏指数对脓毒症患者并发急性呼吸窘迫综合征的预测价值[J].实用临床医药杂志,2025,29(18):1-5,13.
[22]吕昭怡,王六菊,徐梅先,等.脓毒症患儿肠道菌群结构与炎症反应相关性的前瞻性队列研究[J].中国当代儿科杂志,2024,26(6):567-574.
[23]ZOU J,SHANKAR N.Roles of TLR/MyD88/MAPK/NF-κB signaling pathways in the regulation of phagocytosis and proinflammatory cytokine expression in response to E.faecalis infection[J].PLoS One,2015,10(8):e0136947.
[24]田云芬,王斌,章放香.短链脂肪酸多靶点调控脓毒症器官保护的研究进展[J].实用医学杂志,2025,41(13):2105-2110.
[25]张炤杰.MODS患者肠道菌群紊乱与机体免疫应答、炎症反应的相关性分析[J].海南医学院学报,2017,23(13):1780-1782,1786.
相似文献/References:
[1]李文军,于代华,宗 雷,等.脾多肽注射液对脓毒症患者血清炎症因子及免疫功能的影响*[J].陕西医学杂志,2019,(4):463.
LI Wenjun,YU Daihua,ZONG Lei,et al.Effect of spleen peptide injection on serum inflammatory factors and immune function in patients With Sepsis[J].,2019,(8):463.
[2]商跃云,张 慧,林书祥,等.脓毒症患儿外周血CD4+T细胞Bip、ATF6及DDIT3表达水平变化[J].陕西医学杂志,2019,(6):706.
SHSNG Yueyun,ZHANG Hui,LIN Shuxiang,et al.Changes of immunoglobulin binding protein, activating transcription factor 6 and DNA-damage-inducible transcript 3 protein levels in CD4+T cells in children with sepsis[J].,2019,(8):706.
[3]田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510.
TIAN Yongchao..Progress in prevention and treatment of intestinal mucosal barrier dysfunction in sepsis[J].,2020,49(8):510.
[4]王 婷,韦小碗,杨 亮,等.脓毒症患者血清PCT、CRP、IL-6 和IL-10水平检测及临床意义[J].陕西医学杂志,2020,49(11):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
WANG Ting,WEI Xiaowan,YANG Liang,et al.Expression of serum PCT,CRP,IL-6 and IL-10 in patients with sepsis and their clinical diagnostic value[J].,2020,49(8):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
[5]肖武强,董 磊,吴先正△.急性胃肠损伤分级联合D-乳酸、内毒素水平测定对脓毒症患者预后的评估价值*[J].陕西医学杂志,2020,49(12):1577.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.010]
[6]张 瑜,王 娟.脓毒症并发急性呼吸窘迫综合征患者血清血管内皮钙黏蛋白、血管生成素2表达及与预后相关性研究[J].陕西医学杂志,2022,51(2):176.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.011]
ZHANG Yu,WANG Juan.Expression of serum vascular endothelial cadherin and angiopoietin 2 in sepsis patients complicated with acute respiratory distress syndrome and their correlation with prognosis[J].,2022,51(8):176.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.011]
[7]王兴程,张向宁,侯崇智,等.右美托咪定在脓毒症治疗中的作用及机制研究进展[J].陕西医学杂志,2022,51(3):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
WANG Xingcheng,ZHANG Xiangning,HOU Chongzhi,et al.Research progress on the role and mechanism of dexmedetomidine in the treatment of sepsis[J].,2022,51(8):382.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.028]
[8]梁 红,霍红艳.右美托咪定对盲肠结扎穿孔术诱导的脓毒症大鼠急性肺损伤保护作用及其与磷酸化JAK激酶2/酪氨酸磷酸化通路的关系[J].陕西医学杂志,2023,52(1):12.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.003]
LIANG Hong,HUO Hongyan.Protective effect of dexmedetomidine on CLP-induced acute lung injury in rats with sepsis and its relationship with JAK2/STAT3 pathway[J].,2023,52(8):12.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.003]
[9]廖崇皓,徐岸楠,李世瑶,等.血清壳多糖酶3样蛋白1和几丁质酶1在脓毒症新生儿中的表达变化及其临床价值研究[J].陕西医学杂志,2024,(3):368.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.017]
LIAO Chonghao,XU Annan,LI Shiyao,et al.Expression changes of serum chitosinase 3-like protein 1 and chitinase 1 in neonatal sepsis and their clinical value[J].,2024,(8):368.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.017]
[10]吴泽华,李跃东,戴莹莹,等.降钙素原、C反应蛋白、白细胞计数和中性粒细胞比率在重症医学科脓毒症治疗预后判断中的临床价值[J].陕西医学杂志,2024,(4):540.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.023]